Metastatic Cancer Colorectal research hub

iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients on Nivolumab and Ipilimumab

This study looks at how well a combination of two drugs, nivolumab and ipilimumab, works for people with advanced bowel cancer that has spread. It wants to find the best ways to measure if the treatment is shrinking the cancer using scans.